Induced Infringement under US Patent Law

June 2022Intellectual Property Pharmaceutical

Abstract

Induced infringement finds its basis in 35 U.S.C. § 271(b) and holds a person, liable if he actively causes infringement, even if the actor himself is not the direct infringer. This is one of the doctrines that helps protect, for limited time, the inventors’ exclusive right to their inventions, essentially by awarding liability to those responsible for infringement. The jurisprudence of induced infringement is rapidly evolving, especially in pharmaceutical cases, and warrants the study of evolution of the doctrine to understand it completely. This paper looks into how United States patent law came to recognize induced infringement, which was earlier not separate from contributory infringement. This paper further explores the development of the doctrine over the years. It also looks into different aspects that make up the philosophy of induced infringement and give rise to the essential elements that are required to prove inducement of infringement. Finally, it also discusses case law to show how the doctrine has been applied by the courts to determine liability of those aiding and abetting infringement, if any.

Subscribe to reador

Few pieces of legislation have shaped the modern innovation landscape as profoundly as the Bayh-Dole Act of 1980. By allowing universities, small businesses, and non-profit organizations to retain ownership...Read more

Joanna Brougher

Owner & Principal, BioPharma Law Group PLLC, USA

Bhavya Bhardwaj

Student, University of Pennsylvania, USA

Patent Strategies for Attenuated Pathogen Vaccines

Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more

David Dolberg

Senior Director of Intellectual Property, Sanaria Inc., USA

Ways to Avoid Having your Patents Cellected*

Induced Infringement under US Patent Law

Abstract

Related Papers